[{"data":1,"prerenderedAt":201},["ShallowReactive",2],{"drug-perphenazine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":59,"contraindications":99,"warnings":118,"renal":119,"monitoring":120,"interactions":121,"review":122,"examples":125,"atc":135,"iran":137,"links":161,"populations":178,"usApproval":196},"perphenazine",1,{"fa":7,"en":8},"پرفنازین","Perphenazine","nervous-system",{"fa":11,"en":12},"فنوتیازین (آنتی‌سایکوتیک تیپیک)","Phenothiazine antipsychotic",[14],{"name":15,"market":16},"Trilafon","US",[18,19,7],"trilafon","تریلافون",[21,35,43,51],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-2","tablet","oral","2 mg tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},2,"mg",false,[16],[32],{"source":33,"section":34},"fda-perphenazine","How Supplied",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"tab-4","4 mg tablet",{"amount":39,"unit":28,"perUnit":23,"scored":29},4,[16],[42],{"source":33,"section":34},{"id":44,"form":23,"route":24,"label":45,"concentration":46,"markets":48,"refs":49},"tab-8","8 mg tablet",{"amount":47,"unit":28,"perUnit":23,"scored":29},8,[16],[50],{"source":33,"section":34},{"id":52,"form":23,"route":24,"label":53,"concentration":54,"markets":56,"refs":57},"tab-16","16 mg tablet",{"amount":55,"unit":28,"perUnit":23,"scored":29},16,[16],[58],{"source":33,"section":34},[60,83],{"id":61,"disease":62,"label":63,"population":66,"type":70,"unit":28,"dose":71,"refs":73,"notes":76},"scz","schizophrenia",{"fa":64,"en":65},"اسکیزوفرنی سرپایی — ۴ تا ۸ mg سه بار در روز","Outpatient schizophrenia — 4–8 mg three times daily",{"minAge":67},{"value":68,"unit":69},12,"year","fixed",{"perDose":39,"perDoseMax":47,"dosesPerDay":72},3,[74],{"source":33,"section":75},"Dosage and Administration",[77],{"text":78,"refs":81},{"fa":79,"en":80},"هر چه زودتر به کمترین دوز مؤثر کاهش یابد. بستری: ۸ تا ۱۶ mg دو تا چهار بار، حداکثر ۶۴ mg\u002Fday.","Reduce to the minimum effective dose as soon as possible. Inpatients: 8–16 mg two to four times daily, max 64 mg\u002Fday.",[82],{"source":33,"section":75},{"id":84,"disease":85,"label":86,"population":89,"type":70,"unit":28,"dose":92,"refs":93,"limits":95},"nv","nausea-vomiting",{"fa":87,"en":88},"تهوع و استفراغ شدید — بزرگسال: ۸ تا ۱۶ mg\u002Fday منقسم","Severe nausea\u002Fvomiting — adults: 8–16 mg\u002Fday divided",{"minAge":90},{"value":91,"unit":69},18,{"perDose":39,"perDoseMax":47,"dosesPerDay":27},[94],{"source":33,"section":75},{"maxPerDay":96,"refs":97},24,[98],{"source":33,"section":75},[100,109],{"id":101,"severity":102,"text":103,"refs":106},"ci","block",{"fa":104,"en":105},"کما یا خواب‌آلودگی شدید؛ مصرف زیاد داروهای مضعف CNS؛ دیسکرازی خونی، سرکوب مغز استخوان، آسیب کبدی.","Coma or greatly obtunded; large doses of CNS depressants; blood dyscrasias, marrow depression, liver damage.",[107],{"source":33,"section":108},"Contraindications",{"id":110,"severity":111,"text":112,"refs":115},"dementia","warn",{"fa":113,"en":114},"هشدار جعبه‌ای: افزایش مرگ در سالمندان مبتلا به سایکوز ناشی از دمانس.","Boxed warning: increased mortality in elderly patients with dementia-related psychosis.",[116],{"source":33,"section":117},"Boxed Warning",[],[],[],[],{"status":123,"reviewer":124,"date":124},"unverified",null,[126,131],{"regimen":61,"formulation":36,"input":127,"expect":130},{"ageYears":128,"weightKg":129},30,70,{"perDose":39,"upperPerDose":47},{"regimen":84,"formulation":36,"input":132,"expect":134},{"ageYears":133,"weightKg":129},40,{"perDose":39},[136],"N05AB03",{"status":138,"forms":139,"refs":156},"registered",[140,144,148,152],{"code":141,"en":142,"fa":143},"00972","PERPHENAZINE 2MG TAB","قرص پرفنازین ۲ میلی‌گرم",{"code":145,"en":146,"fa":147},"00973","PERPHENAZINE 4MG TAB","قرص پرفنازین ۴ میلی‌گرم",{"code":149,"en":150,"fa":151},"00974","PERPHENAZINE 5MG\u002F1ML AMP","آمپول پرفنازین ۵ میلی‌گرم \u002F ۱ میلی‌لیتر",{"code":153,"en":154,"fa":155},"00975","PERPHENAZINE 8MG TAB","قرص پرفنازین ۸ میلی‌گرم",[157],{"source":158,"section":159,"url":160},"darooyab-generic","G-1325\u002FPerphenazine","https:\u002F\u002Fwww.darooyab.ir\u002FG-1325\u002FPerphenazine",[162,166,170,173,176],{"kind":163,"url":164,"label":165},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=040226","ANDA040226",{"kind":167,"url":168,"label":169},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=5fbfe9da-26e8-4705-98f3-42acd3d7b439","FDA Perphenazine",{"kind":171,"url":172,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682165.html",{"kind":174,"url":175,"label":136},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=N05AB03",{"kind":177,"url":160,"label":8},"darooyab",{"pregnancy":179,"geriatric":188},{"level":180,"text":181,"quote":184,"refs":185},"caution",{"fa":182,"en":183},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Perphenazine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[186],{"source":33,"section":187},"Pregnancy",{"level":189,"text":190,"quote":193,"refs":194},"avoid",{"fa":191,"en":192},"برچسب: در سالمندان هشدار جدی یا پرهیز.","Label: serious warning or avoid in older adults.","WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.",[195],{"source":33,"section":117},{"kind":197,"refs":198,"id":165},"ANDA",[199],{"source":33,"section":200},"SPL approval \u002F marketing category",1792191877324]